Using mTOR Inhibitors in the Prevention of BK Nephropathy
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Sirolimus (Primary) ; Mycophenolic acid; Tacrolimus
- Indications Kidney disorders; Renal transplant rejection; Viraemia
- Focus Therapeutic Use
- 18 Jul 2017 Status changed from active, no longer recruiting to completed.
- 28 Jan 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016, according to ClinicalTrials.gov record.
- 28 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016, according to ClinicalTrials.gov record.